<DOC>
	<DOCNO>NCT00304681</DOCNO>
	<brief_summary>The purpose study determine effectiveness safety OROS*methylphenidate/CONCERTA* vs. immediate release methylphenidate treatment ADHD specifically child behavioural difficulty afternoon/after-school evening period .</brief_summary>
	<brief_title>An Effectiveness Safety Study CONCERTA* v . Immediate Release Methylphenidate ( IR MPH ) Attention Deficit Hyperactivity Disorder Children</brief_title>
	<detailed_description>Methylphenidate , namely immediate release methylphenidate primary stimulant use treatment child Attention Deficit Hyperactivity Disorder ( ADHD ) . Immediate release methylphenidate limitation related time course action.As morning dose wear , inattention may increase late-morning class . Similarly , midday dose wearing , child may experience difficulty concentrate homework . The second problem relate compliance midday late afternoon dosing . Children feel stigmatize embarrassed trip nurse 's office medication may skip dos result . In case , school nurse may available policy prohibit staff administer drug child may require self-administer drug . CONCERTAÂ® develop overcome limitation . The purpose study see effective safe Concerta* vs. immediate release methylphenidate child ADHD . Patients take either Concerta* ( 18 , 27 , 36 , 54 mg ) Immediate Release Methylphenidate tablet ( maximum 60mg/day ) orally every morning 8 week .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>Patients must 6 12 year age inclusive , diagnosis Attention Deficit Hyperactivity Disorder ( ADHD ) define DSMIV establish clinical interview investigator corroborate SNAPIV parent rating scale , opinion parents/caregivers exhibit significant afterschool/evening behavioural difficulty 12 hour coverage desire Eligible patient evaluate minimum 3 day washout period without ADHD medication In addition , patient must also CGISeverity score , baseline `` moderate '' , `` mark '' , `` severe '' `` extremely severe '' order eligible Patients could prior treatment ADHD presently take something could ADHD medication treatment past No patient mark anxiety , tension , aggression agitation , glaucoma , ongoing seizure disorder , psychotic disorder , diagnosis Tourette 's disorder , family history Tourette 's disorder , bipolar disorder , suspect mental retardation , significant learning disability , eat disorder history one , preexist gastrointestinal narrow No patient inability swallow medication whole , unstable medical illness exclude</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Attention Deficit Hyperactivity Disorder</keyword>
	<keyword>OROS* Methylphenidate</keyword>
</DOC>